As of May 14, 2026, Heron Therapeutics's top three insider holders are Capital Management Lp Rubric (TenPercentOwner, 30.05Mn shares), Capital Management Lp Rubric (TenPercentOwner, 30.05Mn shares), Capital Management Lp Rubric (TenPercentOwner, 30.05Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Capital Management Lp Rubric | - | 0 | 30,046,828 | 17 Oct, 2025 |
| Capital Management Lp Rubric | - | 0 | 30,046,828 | 17 Oct, 2025 |
| Capital Management Lp Rubric | - | 0 | 30,046,828 | 17 Oct, 2025 |
| Adam Morgan | - | 0 | 8,753,290 | 12 Aug, 2025 |
| Adam Morgan | - | 0 | 8,753,290 | 12 Aug, 2025 |
| Adam Morgan | - | 0 | 8,753,290 | 12 Aug, 2025 |
| Adam Morgan | - | 0 | 6,986,744 | 25 Jul, 2023 |
| Adam Morgan | - | 0 | 6,986,744 | 25 Jul, 2023 |
| Adam Morgan | - | 0 | 6,986,744 | 25 Jul, 2023 |
| Craig A Collard | Chief Executive Officer | 662,052 | 0 | 21 Apr, 2026 |
| Ira Duarte | Evp, Chief Financial Officer | 215,876 | 0 | 21 Apr, 2026 |
| William P Forbes | Evp, Chief Development Officer | 185,647 | 0 | 21 Apr, 2026 |
| Barry D Quart | Chief Executive Officer | 177,989 | 0 | 17 Jan, 2023 |
| Adam Morgan | - | 123,737 | 0 | 03 Feb, 2026 |
| Adam Morgan | - | 123,737 | 0 | 03 Feb, 2026 |
| Adam Morgan | - | 123,737 | 0 | 03 Feb, 2026 |
| Susan Rodriguez | - | 87,180 | 0 | 04 Feb, 2025 |
| Susan Rodriguez | - | 87,180 | 0 | 04 Feb, 2025 |
| Lisa Peraza | Vp, Chief Accounting Officer | 55,907 | 0 | 16 Jan, 2024 |
| Lisa Peraza | Vp, Chief Accounting Officer | 55,907 | 0 | 16 Jan, 2024 |
| Lisa Peraza | Vp, Chief Accounting Officer | 55,907 | 0 | 16 Jan, 2024 |
| Craig A Johnson | - | 53,960 | 0 | 03 Feb, 2026 |
| Craig A Johnson | - | 53,960 | 0 | 03 Feb, 2026 |
| Waage Christian | - | 53,960 | 0 | 03 Feb, 2026 |
| Craig A Johnson | - | 53,960 | 0 | 03 Feb, 2026 |
| Michael Kaseta | - | 53,960 | 0 | 03 Feb, 2026 |
| Thomas Cusack | - | 53,960 | 0 | 03 Feb, 2026 |
| Sharmila Dissanaike | - | 53,960 | 0 | 03 Feb, 2026 |
| Stephen Davis | - | 52,032 | 0 | 20 Dec, 2022 |
| John Poyhonen | President Cco | 46,648 | 0 | 17 Apr, 2023 |
| John Poyhonen | President Cco | 46,648 | 0 | 17 Apr, 2023 |
| David Leslie Szekeres | Evp, Chief Operating Officer | 33,754 | 0 | 17 Jul, 2023 |
| David Leslie Szekeres | Evp, Chief Operating Officer | 33,754 | 0 | 17 Jul, 2023 |
| David Leslie Szekeres | Evp, Chief Operating Officer | 33,754 | 0 | 17 Jul, 2023 |
| Kimberly Manhard | Evp, Drug Development | 28,330 | 0 | 17 Apr, 2023 |
| Kimberly Manhard | Evp, Drug Development | 28,330 | 0 | 17 Apr, 2023 |
| Kimberly Manhard | Evp, Drug Development | 28,330 | 0 | 17 Apr, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 19 Apr, 2026 | Ira Duarte | Common Stock | A | 3,874 | - | 215,876 | D | M |
| 19 Apr, 2026 | Craig A Collard | Common Stock | A | 13,797 | - | 662,052 | D | M |
| 19 Apr, 2026 | William P Forbes | Common Stock | A | 3,874 | - | 185,647 | D | M |
| 19 Apr, 2026 | William P Forbes | Restricted Stock Units | D | 3,874 | $0.00 | 27,120 | D | M |
| 19 Apr, 2026 | Craig A Collard | Restricted Stock Units | D | 13,797 | $0.00 | 96,758 | D | M |
| 19 Apr, 2026 | Ira Duarte | Restricted Stock Units | D | 3,874 | $0.00 | 27,120 | D | M |
| 03 Apr, 2026 | Craig A Collard | Common Stock | A | 62,500 | - | 648,255 | D | M |
| 03 Apr, 2026 | Craig A Collard | Restricted Stock Units | D | 62,500 | $0.00 | 62,500 | D | M |
| 30 Jan, 2026 | Thomas Cusack | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Mark Earl Hensley | Restricted Stock Units | A | 188,315 | $0.00 | 188,315 | D | A |
| 30 Jan, 2026 | Waage Christian | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Craig A Johnson | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | Adam Morgan | Common Stock | A | 53,960 | $0.00 | 123,737 | D | A |
| 30 Jan, 2026 | Ira Duarte | Restricted Stock Units | A | 216,562 | $0.00 | 216,562 | D | A |
| 30 Jan, 2026 | Mark Earl Hensley | Restricted Stock Units | A | 188,315 | $0.00 | 188,315 | D | A |
| 30 Jan, 2026 | Adam Morgan | Common Stock | A | 53,960 | $0.00 | 123,737 | D | A |
| 30 Jan, 2026 | Adam Morgan | Common Stock | A | 53,960 | $0.00 | 123,737 | D | A |
| 30 Jan, 2026 | Craig A Johnson | Common Stock | A | 53,960 | $0.00 | 53,960 | D | A |
| 30 Jan, 2026 | William P Forbes | Restricted Stock Units | A | 188,315 | $0.00 | 188,315 | D | A |
| 30 Jan, 2026 | Mark Earl Hensley | Restricted Stock Units | A | 188,315 | $0.00 | 188,315 | D | A |